For grade 3/4 thrombocytopenia, the TPO-RAs group showed a lower incidence compared to placebo (21.4% vs. 34.7%, OR = 0.50; 95% CI: 0.27–0.93) (I2 = 0.0%, p = 0.548) (Figure 3A). The gene discussed is TPO; the disease is Thrombocytopenia.